Company / Operating Cash Flow per Share
CG Oncology, Inc. Operating Cash Flow per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.71
FY2025
5-year range
-$10.55 / -$1.26
FY2023-FY2025
Trend
-35.9%
vs FY2024
Sector context
#141 of 212
Health Care
What the data says
At $-1.71, CG Oncology, Inc.'s operating cash flow per share ranks #141 of 212 in the Health Care sector. Improved from $-10.55 to $-1.71 over the past 2 years.
Based on SEC 10-K filings.
-1.71 in FY2025.
Improved from $-10.55 to $-1.71 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#141 of 212 in Health CareTop 67% of 212This company -$1.71 Sector average -$14.69
▼
+88.3% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 35.9% year-over-year.
- Ranks #141 out of 212 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 8.02 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.71 | -35.9% |
| FY2024 | -$1.26 | +88.1% |
| FY2023 | -$10.55 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026